Search Within

Alan Loh Ho

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (32)
  2. Meeting Abstract (25)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (59)
  2. Epidemiology and Biostatistics (59)
  3. Head and Neck Service (59)
  4. Solid Tumor Oncology Division (59)
  5. Biostatistics Service (50)
  6. Department of Pathology and Laboratory Medicine (40)

More Groups

People
  1. David Pfister (30)
  2. Eric Sherman (29)
  3. Lara Dunn (21)
  4. Nora Katabi (19)
  5. Sofia Haque (18)
  6. James Fagin (16)

More People

Years
  1. 2024 (8)
  2. 2023 (7)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Annals of Oncology (5)
  3. Clinical Cancer Research (4)
  4. International Journal of Radiation Oncology, Biology, Physics (4)
  5. European Journal of Nuclear Medicine and Molecular Imaging (3)
  6. American Journal of Surgical Pathology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Oxford University Press (7)
  3. American Association for Cancer Research (6)
  4. Springer (6)
  5. Elsevier Inc. (5)
  6. Nature Publishing Group (3)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Mohamadpour, M.; Sherman, E. J.; Kriplani, A.; Fetten, J. V.; Dunn, L.; Michel, L. S.; Hung, K. W.; Baxi, S. S.; McDonald, E.; Conybeare, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy
    Journal Article

    Boucai, L.; Saqcena, M.; Kuo, F.; Grewal, R. K.; Socci, N.; Knauf, J. A.; Krishnamoorthy, G. P.; Ryder, M.; Ho, A. L.; Ghossein, R. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • PTEN loss-of-function mutations prevalent in HRAS-mutant cancers results in resistance to targeted therapy
    Meeting Abstract

    Nigam, A.; Chatila, W. K.; Krishnamoorthy, G. P.; Ho, A. L.; Fagin, J. A.; Schultz, N. D.; Untch, B. R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial
    Journal Article

    Riaz, N.; Sherman, E.; Pei, X.; Schòˆder, H.; Grkovski, M.; Paudyal, R.; Katabi, N.; Selenica, P.; Yamaguchi, T. N.; Ma, D.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save